# ABSORB II Randomized Controlled Trial

> **NCT01425281** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 501 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Abbott Vascular XIENCE Everolimus Eluting Coronary Stent System
- **DEVICE:** Abbott Vascular ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System

## Key facts

- **NCT ID:** NCT01425281
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2016-07
- **Final completion:** 2018-05-23
- **Target enrollment:** 501 (ACTUAL)
- **Last updated:** 2019-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01425281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01425281, "ABSORB II Randomized Controlled Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01425281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*